In an industry-first, the company Synchron and Mount Sinai Hospital in New York have enrolled their first human patient in a U.S. clinical trial called COMMAND to evaluate an endovascular ...

Synchron has raised $200 million to support commercialization of its brain computer interface platform, the company said Thursday. The Series D round will fund preparations to launch Synchron's ...

A patient with ALS in Australia is the first person to tweet a message to the world using only direct thought via the Stentrode™ brain computer interface NEW YORK & MELBOURNE, Australia–(BUSINESS WIRE ...

A new brain implant now lets people control Apple devices, such as iPads, iPhones and the Vision Pro, using only their thoughts. Synchron, an endovascular brain-computer interface (BCI) company based ...

The first American has been implanted with a revolutionary new brain-computer interface (BCI) at Mount Sinai Health System in New York City as part of Synchron’s COMMAND trial. This U.S. clinical ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Synchron has raised $200 million to support ...

Synchron was originally spun out of Melbourne University, but like many technology companies struggling to raise capital in Australia moved to the US to access funding. Synchron’s technology is ...

With Neuralink’s device, a robot surgically inserts a device into the brain that can then decode some brain activity and connect the brain signals to computers and other machines. A person paralyzed ...

Science fiction has long imagined a world where our brains interact with machines to restore and augment our abilities—think of the neural implants that connected to Geordi La Forge’s visor in Star ...